Drawing for SARCLISA ESCENA

USPTO serial 99697996

SARCLISA ESCENA

Reviewed by CopyMark Law Group

Status 819
Filing date
Status date
Registration date
—
Examiner
ELLINGER FATHY, JESSICA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SARCLISA ESCENA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexandra Kochian

Alexandra Kochian Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St.,17th FLNew York, NY 10036

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of multiple myelomaACTIVEJul 16, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 3, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Nov 3, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 2, 2026IUAFUSE AMENDMENT FILED—
Nov 2, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 15, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 23, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 23, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jun 23, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 23, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 9, 2026DOCKASSIGNED TO EXAMINER—
May 15, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 1, 2026AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Apr 1, 2026ALIEASSIGNED TO LIE—
Mar 31, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 12, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 12, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance